Trastuzumab vs Yttrium Y 90 Ibritumomab Tiuxetan

## Trastuzumab vs Yttrium Y 90 Ibritumomab Tiuxetan: Overview

This comparison examines the pharmacological differences between **Trastuzumab** and **Yttrium Y 90 Ibritumomab Tiuxetan**.

## Mechanism of Action

**Trastuzumab**: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

## Pharmacokinetics

**Half-life**: Trastuzumab — 28 days; Yttrium Y 90 Ibritumomab Tiuxetan — N/A.

## Chemical Properties

**Type**: Trastuzumab — Antibody; Yttrium Y 90 Ibritumomab Tiuxetan — Antibody.